YAP/TAZ activation can also contribute to metabolic reprograming in cancer cells, specifically in the upregulation of proteins that facilitate increased glucose uptake and glycolytic flux such as GLUT1-3, phosphofructokinase and others (Liu et al., 2021). Here, YAP1 is linked to cancer.